SCHEMBL9183264

SCHEMBL9183264

O=[C]N(c1ccccc1)c1ccccn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.39
TSHR P16473 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39
POLB P06746 1/20 0.37
USP2 O75604 1/20 0.37
KMT2A Q03164 2/20 0.37
CHRM2 P08172 1/20 0.37
ADRA2A P08913 1/20 0.37
ADRA2B P18089 1/20 0.37
ADRA2C P18825 1/20 0.37
DRD1 P21728 1/20 0.37
SLC6A2 P23975 1/20 0.37
HTR2A P28223 1/20 0.37
SLC6A4 P31645 1/20 0.37
ADRA1A P35348 1/20 0.37
HRH1 P35367 1/20 0.37
OPRK1 P41145 1/20 0.37
SLC6A3 Q01959 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5113337 0.90 CYP2D6 (0.42) ALDH1A1SMN1; SMN2TSHRCYP2D6CYP2C19
SCHEMBL6225489 0.83 USP2 (0.35) ALDH1A1SMN1; SMN2POLBUSP2KMT2A
SCHEMBL8759441 0.82 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2TSHRCYP2D6CYP2C19
SCHEMBL19994990 0.82 CYP2D6 (0.42) ALDH1A1SMN1; SMN2TSHRCYP2D6CYP2C19
SCHEMBL104821 0.78 ALDH1A1 (0.42) ALDH1A1TSHRCYP2D6CYP2C19POLB
SCHEMBL16320531 0.75 NPSR1 (0.48) ALDH1A1TSHRPOLBKMT2ARAB9A
SCHEMBL9276044 0.75 KMT2A (0.43) ALDH1A1CYP2D6CYP2C19POLBKMT2A
SCHEMBL1448809 0.75 CYP2D6 (0.41) ALDH1A1SMN1; SMN2TSHRCYP2D6CYP2C19
SCHEMBL229388 0.74 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2TSHRCYP2D6CYP2C19
SCHEMBL4647647 0.74 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2TSHRCYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5405843-A Anticancer drug potentiators MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1995-04-11 US disclosed
EP-0363212-B1 Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components MITSUI TOATSU CHEMICALS (JP) 1995-01-04 EP disclosed
US-5204348-A Quinoline derivatives MITSUI TOATSU CHEMICALS INC. (JP) 1993-04-20 US disclosed
US-5112817-A Anticancer Drug Potentiators MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1992-05-12 US disclosed
EP-0363212-A2 Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components MITSUI TOATSU CHEMICALS, Inc. (JP) 1990-04-11 EP disclosed